Literature DB >> 19320892

beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing.

Bruna Romana-Souza1, Jeanine S Santos, Andréa Monte-Alto-Costa.   

Abstract

The sympathetic nervous system plays an important role in wound healing, but its mechanism of action is poorly understood. The aim of this study was to investigate the effects of beta- and alpha-adrenoceptor blockade on cutaneous wound healing. Male rats were treated with propranolol (beta1- and beta2-antagonist), atenolol (beta1-antagonist), or phentolamine (alpha1- and alpha2-antagonist) dissolved in drinking water. A full-thickness excisional lesion was created and the wound area was measured. Fourteen days after wounding, lesions and adjacent skin were removed, formalin-fixed, and paraffin-embedded. Sections were stained with hematoxylin-eosin and toluidine blue, and immunostained for alpha-smooth muscle actin and proliferating cell nuclear antigen. Wound contraction was delayed in propranolol- and atenolol-treated animals but not in phentolamine-treated animals. Reepithelialization was decreased only in propranolol-treated animals. beta1- and beta2-adrenoceptor blockade delayed leukocyte migration, epidermal and connective tissue cell proliferation, myofibroblastic differentiation, and mast cell migration. The volume density of blood vessels was increased in the propranolol- and atenolol-treated animals compared with controls. The levels of matrix metalloproteases (MMP-2 and MMP-9) decreased in the propranolol- and atenolol-treated animals. alpha1- and alpha2-adrenoceptor blockade only affected leukocyte migration, epithelial and connective tissue cell proliferation, and pro-MMP-9 levels. In conclusion, beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays cutaneous wound healing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320892     DOI: 10.1111/j.1524-475X.2008.00453.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  7 in total

1.  Deletion of the α2A/α2C-adrenoceptors accelerates cutaneous wound healing in mice.

Authors:  Bruna Romana-Souza; Adriana P Nascimento; Patricia C Brum; Andréa Monte-Alto-Costa
Journal:  Int J Exp Pathol       Date:  2014-09-03       Impact factor: 1.925

2.  Pharmacological targeting of β-adrenergic receptor functions abrogates NF-κB signaling and MMP-9 secretion in medulloblastoma cells.

Authors:  Borhane Annabi; Eric Vaillancourt-Jean; Alexander G Weil; Richard Béliveau
Journal:  Onco Targets Ther       Date:  2010-11-15       Impact factor: 4.147

3.  β2AR antagonists and β2AR gene deletion both promote skin wound repair processes.

Authors:  Christine E Pullar; Gabrielle S Le Provost; Andrew P O'Leary; Sian E Evans; Brian S Baier; R Rivkah Isseroff
Journal:  J Invest Dermatol       Date:  2012-04-12       Impact factor: 8.551

Review 4.  Biomechanical Factors in Psoriatic Disease: Defective Repair Exertion as a Potential Cause. Hypothesis Presentation and Literature Review.

Authors:  Şükrü Burak Tönük; Zeynep Rezan Yorgancıoğlu
Journal:  ACR Open Rheumatol       Date:  2019-08-08

5.  Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis.

Authors:  Jessica Stiles; Clarissa Amaya; Robert Pham; Rebecca K Rowntree; Mary Lacaze; Arlynn Mulne; Joyce Bischoff; Victor Kokta; Laura E Boucheron; Dianne C Mitchell; Brad A Bryan
Journal:  Exp Ther Med       Date:  2012-08-03       Impact factor: 2.447

6.  Evaluation of therapeutic intervention with a natural product in cutaneous wound healing: the use of capybara oil.

Authors:  Polyana Cury Marinho; Rodrigo Neto-Ferreira; Jorge José de Carvalho
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

7.  Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis.

Authors:  Andrew P O'Leary; James M Fox; Christine E Pullar
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.